Evidence map›Paper›PMID 21673231›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2011

Enhancing mitochondrial respiration suppresses tumor promoter TPA-induced PKM2 expression and cell transformation in skin epidermal JB6 cells.

Jennifer A Wittwer, Delira Robbins, Fei Wang, Sarah Codarin, Xinggui Shen, Christopher G Kevil, Ting-Ting Huang, Holly Van Remmen, Arlan Richardson, Yunfeng Zhao

Open access · bronzeAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. UCP2 knockout suppresses mouse skin carcinogenesis.Cancer prevention research (Philadelphia, Pa.) · 2015
    Article
  9. Article
  10. Article
  11. Article
  12. Manganese superoxide dismutase in cancer prevention.Antioxidants & redox signaling · 2014
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Jennifer A WittwerDepartment of Pharmacology, Toxicology & Neuroscience, LSU Health Sciences Center-Shreveport, Shreveport, LA 71130, USA.
Delira Robbins
Fei Wang
Sarah Codarin
Xinggui Shen
Christopher G Kevil
Ting-Ting Huang
Holly Van Remmen
Arlan Richardson
Yunfeng Zhao
Stanford University · USThe Ohio State University · USLouisiana State University Health Sciences Center Shreveport · USThe University of Texas Health Science Center at San Antonio · US

Funding

Mitochondrial translocation of p53 and its interaction with manganese superoxide R03CA128077 · NCI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ZHAO, YUNFENG · 2007 to 2008
$147k
PKM2 inhibition and redox regulation in chemopreventionR03CA167689 · NCI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ZHAO, YUNFENG · 2012 to 2013
$140k
BLRD VA I01 BX000517NCI NIH HHS R03 CA128077NCI NIH HHS R03CA-128077NCI NIH HHS R03 CA167689
6 · The paper itself

Abstract

Differentiated cells primarily metabolize glucose for energy via the tricarboxylic acid cycle and oxidative phosphorylation, but cancer cells thrive on a different mechanism to produce energy, characterized as the Warburg effect, which describes the increased dependence on aerobic glycolysis. The M2 isoform of pyruvate kinase (PKM2), which is responsible for catalyzing the final step of aerobic glycolysis, is highly expressed in cancer cells and may contribute to the Warburg effect. However, whether PKM2 plays a contributing role during early cancer development is unclear. In our studies, we have made an attempt to elucidate the effects of varying mitochondrial respiration substrates on skin cell transformation and expression of PKM2. Tumorigenicity in murine skin epidermal JB6 P+ (promotable) cells was measured in a soft agar assay using 12-O-tetradecanoylphorbol-13-acetate (TPA) as a tumor promoter. We observed a significant reduction in cell transformation upon pretreatment with the mitochondrial respiration substrate succinate or malate/pyruvate. We observed that increased expression and activity of PKM2 in TPA-treated JB6 P+ cells and pretreatment with succinate or malate/pyruvate suppressed the effects. In addition, TPA treatment also induced PKM2 whereas PKM1 expression was suppressed in mouse skin epidermal tissues in vivo. In comparison with JB6 P+ cells, the nonpromotable JB6 P- cells showed no increase in PKM2 expression or activity upon TPA treatment. Knockdown of PKM2 using a siRNA approach significantly reduced skin cell transformation. Thus, our results suggest that PKM2 activation could be an early event and play a contributing role in skin tumorigenesis.

Indexed as

AnimalsCell RespirationCell Transformation, NeoplasticHumansMalatesMiceMice, Inbred C57BLMice, Inbred DBAMitochondriaProtein IsoformsPyruvate KinasePyruvic AcidRNA, Small InterferingSkinSkin NeoplasmsSuccinic AcidMalatesmalic acidProtein IsoformsPyruvate KinasePyruvic AcidRNA, Small InterferingSuccinic AcidSuperoxide DismutaseTetradecanoylphorbol Acetate

Identifiers

PMID21673231
PMCPMC4827450
OpenAlexW2110861686

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.